Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NBP328351B

CD4 Antibody Biotin - (Research Grade tregalizumab Biosimilar), R&D Systems™
SDP

Catalog No. NBP328351B
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP328351B 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP328351B Supplier R&D Systems Supplier No. NBP328351B

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

Description

A Novus product, part of R&D Systems. Human Monoclonal Antibody

CD4 Monoclonal antibody specifically detects CD4 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay

Specifications

Antigen CD4
Applications Flow Cytometry, ELISA, Functional Assay
Classification Monoclonal
Conjugate Biotin
Formulation PBS
Gene Alias CD_antigen: CD4, CD4, CD4 antigen, CD4 antigen (p55), CD4 molecule, CD4 receptor, CD4mut, T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4
Host Species Human
Immunogen CD4
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Adaptive Immunity, Cell Biology, Cellular Markers, Cytokine Research, Immunology, Innate Immunity, Regulatory Immunology, Signal Transduction, Stem Cell Markers
Primary or Secondary Primary
Gene ID (Entrez) 920
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG1
Product Line Novus
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.